Disclosures for "Dose Reduction Timing for Concomitant Antiseizure Medications: Post-hoc Analysis of a Phase 3, Open-label Study of Cenobamate for Treatment of Uncontrolled Focal Seizures"
-
Louis Ferrari has received personal compensation for serving as an employee of SK Life science.
-
Dr. Kamin has received personal compensation for serving as an employee of SK LIFE SCIENCE INC.
-
The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for SK Life Science.